14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $65.50 $83.89 Wednesday, 24th Apr 2024 AXSM stock ended at $71.17. This is 2.61% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 4.61% from a day low at $69.92 to a day high of $73.14.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Jan 05, 2024 $81.07 $82.67 $79.63 $82.31 821 604
Jan 04, 2024 $78.07 $85.76 $77.62 $81.99 1 534 936
Jan 03, 2024 $76.95 $77.82 $75.41 $76.09 415 003
Jan 02, 2024 $78.60 $80.95 $76.00 $77.06 648 378
Dec 29, 2023 $79.53 $80.05 $78.40 $79.59 475 191
Dec 28, 2023 $83.66 $84.24 $79.15 $79.62 493 821
Dec 27, 2023 $79.53 $83.80 $79.14 $83.61 1 189 975
Dec 26, 2023 $77.75 $79.47 $77.51 $79.37 511 698
Dec 22, 2023 $74.28 $78.39 $73.24 $76.82 1 186 879
Dec 21, 2023 $71.08 $73.14 $70.97 $72.48 414 601
Dec 20, 2023 $73.51 $73.51 $70.23 $70.55 468 661
Dec 19, 2023 $73.88 $74.89 $72.57 $73.85 398 759
Dec 18, 2023 $72.44 $74.00 $71.03 $73.20 340 773
Dec 15, 2023 $73.64 $74.39 $71.80 $72.99 637 007
Dec 14, 2023 $76.05 $76.05 $71.50 $73.27 884 643
Dec 13, 2023 $71.74 $74.52 $70.55 $74.44 730 775
Dec 12, 2023 $70.00 $70.77 $69.07 $70.16 364 937
Dec 11, 2023 $70.00 $70.17 $67.84 $69.65 402 079
Dec 08, 2023 $70.97 $72.78 $69.49 $70.18 655 592
Dec 07, 2023 $69.93 $72.54 $67.88 $70.23 624 481
Dec 06, 2023 $68.99 $71.25 $67.92 $69.35 545 468
Dec 05, 2023 $67.46 $69.31 $67.16 $68.59 385 724
Dec 04, 2023 $68.00 $68.28 $66.71 $67.43 602 869
Dec 01, 2023 $67.48 $68.35 $66.76 $68.00 455 728
Nov 30, 2023 $67.15 $68.08 $66.21 $67.45 519 672
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT